Professor Ruth Dobson

Profile

I am a Consultant Neurologist with extensive experience in multiple sclerosis and related disorders. I currently lead a number of research projects including a multi-centre pharmacovigilance study in MS (OPTIMISE:MS), the UK MS Pregnancy Register, and a multi-ethnic genetics study in MS (ADAMS). I am interested in the role of modifiable factors such as Epstein Barr virus and vitamin D in the development of MS and its subsequent complications, and am using routinely acquired healthcare data to better understand this. I have been awarded research grants from MS Society, NMSS, BMA Foundation, MRC and NIHR.

I studied at Clare College Cambridge before graduating with distinction in clinical sciences from University College London. I completed her PhD in 2013, having received funding from the Guarantors of Brain and an MS Society/ABN Clinical Research fellowship for this work. I have been awarded numerous scholarships, and was an RCP Emerging Female Leader fellow in 2019.

I have a keen interest in equality and diversity, both within MS and the wider academic field. I lead national and international mentorship schemes, and am a non-executive board member of International Women in MS. I am deputy Academic Lead for EDI within QMUL Faculty of Medicine and Dentistry, and sit on the FMD Athena Swan committee. I have also provided input into EDI strategies for external organisations, such as the MS Society.

Outside of work I spend much of my time looking after my two daughters, and enjoy swimming and playing the cello when I get a chance.

Research

Publications

Key Publications

COVID-19 Vaccine Response in People with Multiple Sclerosis

Gene-Environment Interactions in Multiple Sclerosis: A UK Biobank Study

Demyelinating Events Following Initiation of Anti-TNFα Therapy in the British Society for Rheumatology Biologics Registry in Rheumatoid Arthritis

Summary-data-based Mendelian randomization prioritizes potential druggable targets for multiple sclerosis

Ethnic and Socioeconomic Associations with Multiple Sclerosis Risk

UK consensus on pregnancy in multiple sclerosis: 'Association of British Neurologists' guidelines

• Bernard Healey SA, Giovannoni G, Noyce A et al. (2023). Impact of multiple sclerosis risk alleles on the plasma proteome.. nameOfConference

  
  

  DOI: 10.1093/brain/awad363

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/91694
• Dobson R, Ovadia C, Mathews J et al. (2023). Prescribing in pregnancy: Navigating risks and benefits. nameOfConference

  
  

  DOI: 10.1136/pn-2023-003812

  
  

  QMRO: qmroHref
• Fan JH, Alexander J, Poole S et al. (2023). Characteristics of multiple sclerosis and demyelinating disease in an Asian American population. nameOfConference

  
  

  DOI: 10.1177/13524585231188486

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/90171
• Chen B, Gomez-Figueroa E, Redenbaugh V et al. (2023). Do Early Relapses Predict the Risk of Long-Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?. nameOfConference

  
  

  DOI: 10.1002/ana.26731

  
  

  QMRO: qmroHref
• Liu C, Pace S, Bromley R et al. (2023). Exposure to medication for neurological disease in pregnancy – time to consider the long-term implications?. nameOfConference

  
  

  DOI: 10.1016/j.eclinm.2023.102157

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/90416
• Leddy S, Dobson R (2023). Multiple sclerosis. nameOfConference

  
  

  DOI: 10.1016/j.mpmed.2023.06.005

  
  

  QMRO: qmroHref
• Dobson R (2023). Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination. nameOfConference

  
  

  DOI: 10.1177/13524585231185247

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/86261
• Dobson R, Jacobs B (2023). Early depressive symptoms and disability accrual in Multiple Sclerosis - a UK MS Register study. nameOfConference

  
  

  DOI: 10.1038/s41598-023-34545-6

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/86258
• Jacobs BM, Schalk L, Dunne A et al. (2023). ADAMS project: A genetic Association study in individuals from Diverse Ancestral backgrounds with Multiple Sclerosis based in the UK. nameOfConference

  
  

  DOI: 10.1136/bmjopen-2023-071656

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/88025
• Gklinos P, Dobson R (2023). Monoclonal Antibodies in Pregnancy and Breastfeeding in Patients with Multiple Sclerosis: A Review and an Updated Clinical Guide. nameOfConference

  
  

  DOI: 10.3390/ph16050770

  
  

  QMRO: qmroHref
• Fan J, Alexander J, Poole S et al. (2023). Characteristics of Multiple Sclerosis and Demyelinating Disease in an Asian American Population (P9-3.009). Tuesday, April 25

  
  

  DOI: 10.1212/wnl.0000000000203972

  
  

  QMRO: qmroHref
• Bove R, Amato MP, Dobson R et al. (2023). Pregnancy Outcomes in Patients With MS Following Exposure to Ofatumumab: Updated Results From the Novartis Safety Database (P9-3.014). Tuesday, April 25

  
  

  DOI: 10.1212/wnl.0000000000202940

  
  

  QMRO: qmroHref
• Oreja-Guevara C, Vukusic S, Pietrasanta C et al. (2023). Données de grossesses et des enfants de femmes recevant ocrélizumab pour le traitement de la sclérose en plaques. nameOfConference

  
  

  DOI: 10.1016/j.neurol.2023.01.672

  
  

  QMRO: qmroHref
• Dobson R (2023). Family planning and multiple sclerosis. nameOfConference

  
  

  DOI: 10.1016/S1474-4422(22)00426-4

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/82424
• Krysko KM, Dobson R, Alroughani R et al. (2023). Family planning considerations in people with multiple sclerosis. nameOfConference

  
  

  DOI: 10.1016/S1474-4422(22)00426-4

  
  

  QMRO: qmroHref
• Dobson R, Jacobs B, Marshall C (2023). Polygenic risk score prediction of Multiple Sclerosis in individuals of South Asian ancestry. nameOfConference

  
  

  DOI: 10.1093/braincomms/fcad041

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/82423
• Dobson R (2023). Menopause in women with multiple sclerosis: clinical symptoms, therapeutic considerations and possible impact on the course of the disease. nameOfConference

  
  

  DOI: 10.12968/bjnn.2023.19.Sup1.S34

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/83643
• Dobson R (2023). Developing evidence-based guidelines for the safety of symptomatic drugs in multiple sclerosis (MS) during pregnancy and breastfeeding: a systematic review and Delphi consensus. nameOfConference

  
  

  DOI: 10.1177/13524585221148094

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/83644
• Iyer P, Dobson R (2023). Multiple Sclerosis in Pregnancy: A Commentary on Disease Modification and Symptomatic Drug Therapies. nameOfConference

  
  

  DOI: 10.1007/s40120-022-00421-0

  
  

  QMRO: qmroHref
• Kuri A, Vickaryous N, Awad A et al. (2023). Vitamin D genetic risk scores in multiple sclerosis. nameOfConference

  
  

  DOI: 10.1007/s00415-022-11466-4

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/82470
• Lee CD, Galetta SL, Dobson R (2023). Management of Possible Multiple Sclerosis. nameOfConference

  
  

  DOI: 10.1056/NEJMclde2300812

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/84507
• Jacobs BM, Tank P, Bestwick JP et al. (2023). Modifiable risk factors for multiple sclerosis have consistent directions of effect across diverse ethnic backgrounds: a nested case–control study in an English population-based cohort. nameOfConference

  
  

  DOI: 10.1007/s00415-023-11971-0

  
  

  QMRO: qmroHref
• Teelucksingh S, Govind RM, Dobson R et al. (2023). Treating Vestibular Migraine When Pregnant and Postpartum: Progress, Challenges and Innovations. nameOfConference

  
  

  DOI: 10.2147/IJWH.S371491

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/84863
• Noyce A (2022). The association between anti-epileptic drugs and incident Parkinson’s disease in UK Biobank. nameOfConference

  
  

  DOI: 10.1001/jamaneurol.2022.4699

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/82500
• Dreyer-Alster S, Achiron A, Giovannoni G et al. (2022). No evidence for an association between alcohol consumption and Multiple Sclerosis risk: a UK Biobank study. nameOfConference

  
  

  DOI: 10.1038/s41598-022-26409-2

  
  

  QMRO: qmroHref
• Simpson-Yap S, Pirmani A, Kalincik T et al. (2022). Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity. nameOfConference

  
  

  DOI: 10.1212/NXI.0000000000200021

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/80533
• Dobson R (2022). Social determinants of health and their impact in multiple sclerosis. nameOfConference

  
  

  DOI: 10.1038/s41582-022-00735-5

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/80535
• Dobson R, Bove R (2022). In Vitro Fertilization and Multiple Sclerosis: Evolving Treatments and Reducing Relapse Risk. nameOfConference

  
  

  DOI: 10.1212/WNL.0000000000201242

  
  

  QMRO: qmroHref
• Dobson R, Bove R (2022). In Vitro Fertilization and Multiple Sclerosis: Evolving Treatments and Reducing Relapse Risk.. nameOfConference

  
  

  DOI: 10.1212/WNL.0000000000201242

  
  

  QMRO: qmroHref
• Simpson-Yap S, Pirmani A, De Brouwer E et al. (2022). Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β. nameOfConference

  
  

  DOI: 10.1016/j.msard.2022.104072

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/80518
• Jacobs BM, Peter M, Giovannoni G et al. (2022). Towards a global view of multiple sclerosis genetics. nameOfConference

  
  

  DOI: 10.1038/s41582-022-00704-y

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/80522
• Hone L, Jacobs BM, Marshall C et al. (2022). Age-specific effects of childhood body mass index on multiple sclerosis risk. nameOfConference

  
  

  DOI: 10.1007/s00415-022-11161-4

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/86260
• Allen-Philbey K, Stennett A, Begum T et al. (2022). Did it hurt? COVID-19 vaccination experience in people with multiple sclerosis. nameOfConference

  
  

  DOI: 10.1016/j.msard.2022.104022

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/79446
• Foote IF, Jacobs BM, Mathlin G et al. (2022). The shared genetic architecture of modifiable risk for Alzheimer's disease: a genomic structural equation modelling study. nameOfConference

  
  

  DOI: 10.1016/j.neurobiolaging.2022.02.016

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/79699
• Bove R, Hellwig K, Pasquarelli N et al. (2022). Ocrelizumab during pregnancy and lactation: Rationale and design of the MINORE and SOPRANINO studies in women with MS and their infants. nameOfConference

  
  

  DOI: 10.1016/j.msard.2022.103963

  
  

  QMRO: qmroHref
• Tallantyre EC, Scurr MJ, Vickaryous N et al. (2022). Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis. nameOfConference

  
  

  DOI: 10.1016/j.msard.2022.103937

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/79178
• Tur C, Dubessy AL, Otero-Romero S et al. (2022). The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021. nameOfConference

  
  

  DOI: 10.1177/13524585211069068

  
  

  QMRO: qmroHref
• Dobson R, Tanasescu R, Gran B (2022). Editorial: Preventing multiple sclerosis. nameOfConference

  
  

  DOI: 10.3389/fneur.2022.982411

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/80121
• Dobson R, Rog D, Ovadia C et al. (2022). Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines. nameOfConference

  
  

  DOI: 10.1136/pn-2022-003426

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/79447
• Dobson R (2022). Preventing Multiple Sclerosis - from evidence to action. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Rivas C, Anand K, Wu AFW et al. (2022). Lessons From the COVID-19 Pandemic to Improve the Health, Social Care, and Well-being of Minoritized Ethnic Groups With Chronic Conditions or Impairments: Protocol for a Mixed Methods Study. nameOfConference

  
  

  DOI: 10.2196/38361

  
  

  QMRO: qmroHref
• Judge-Clayden F, Iyer P, Williams A et al. (2022). Multiple sclerosis, disease modifying therapies and pregnancy. nameOfConference

  
  

  DOI: 10.12968/bjnn.2022.18.sup3.s22

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/80524
• Jensen M, Jacobs B, Dobson R et al. (2022). Lower lymphocyte count is associated with increased risk of Parkinson’s disease. nameOfConference

  
  

  DOI: 10.1136/jnnp-2022-abn.306

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/78813
• Belete D, Jacobs BM, Bestwick JP et al. (2022). Parkinson’s disease determinants, prediction and gene-environment interac- tions: a UK Biobank study. nameOfConference

  
  

  DOI: 10.1136/jnnp-2022-abn.21

  
  

  QMRO: qmroHref
• Dobson R (2022). Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS). nameOfConference

  
  

  DOI: 10.1016/j.msard.2022.103894

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/78457
• Baker D, MacDougall A, Kang AS et al. (2022). Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals?. nameOfConference

  
  

  DOI: 10.1093/cei/uxab015

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/78814
• Simonet C, Bestwick J, Jitlal M et al. (2022). Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK Population. nameOfConference

  
  

  DOI: 10.1001/jamaneurol.2022.0003

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/77358
• Marshall CR, Noyce AJ, Neligan A et al. (2022). Brain health: The hidden casualty of a humanitarian crisis. nameOfConference

  
  

  DOI: 10.1016/j.lanepe.2022.100374

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/77761
• Bothongo PLK, Jitlal M, Parry E et al. (2022). Dementia risk in a diverse population: A single-region nested case-control study in the East End of London. nameOfConference

  
  

  DOI: 10.1016/j.lanepe.2022.100321

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75791
• Vukusic S, Dobson R, Bove RM et al. (2022). Données de grossesses chez des femmes recevant de l’ocrelizumab pour le traitement de la sclérose en plaques. nameOfConference

  
  

  DOI: 10.1016/j.neurol.2022.02.383

  
  

  QMRO: qmroHref
• Dobson R (2022). Peripartum disease activity in moderately and severely disabled women with multiple sclerosis. nameOfConference

  
  

  DOI: 10.1177/2F20552173221104918

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/78456
• Dobson R (2022). Challenges and Opportunities of Real-World Data: Statistical Analysis Plan for the Optimise:MS Multicenter Prospective Cohort Pharmacovigilance Study. nameOfConference

  
  

  DOI: 10.3389/fneur.2022.799531

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/77920
• Noyce A (2022). No evidence for association between polygenic risk of Multiple Sclerosis and MRI phenotypes in ~30,000 healthy adult UK Biobank participants. nameOfConference

  
  

  DOI: 10.1177/2F13524585221075744

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/76333
• Baker D, MacDougall A, Kang AS et al. (2022). Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals?. nameOfConference

  
  

  DOI: 10.1093/cei/uxab015

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/76161
• Hone L, Giovannoni G, Dobson R et al. (2022). Predicting Multiple Sclerosis: Challenges and Opportunities. nameOfConference

  
  

  DOI: 10.3389/fneur.2021.761973

  
  

  QMRO: qmroHref
• Dobson R, Chung K (2022). Natalizumab concentrations during pregnancy in three patients with multiple sclerosis: A clinical commentary. nameOfConference

  
  

  DOI: 10.1177/13524585211069922

  
  

  QMRO: qmroHref
• Huxford B, Haque T, Joseph AB et al. (2022). Parkinson's Disease and Type 2 Diabetes: HbA1c Is Associated with Motor and Cognitive Severity. nameOfConference

  
  

  DOI: 10.1002/mds.28829

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74651
• Dobson R, Marshall C, Noyce A (2022). Social determinants of neurological disease: tackling inequalities. nameOfConference

  
  

  DOI: 10.1016/S1474-4422(22)00005-9

  
  

  QMRO: qmroHref
• Satukijchai C, Mariano R, Messina S et al. (2022). Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the United Kingdom.. nameOfConference

  
  

  DOI: 10.1001/jamanetworkopen.2021.42780

  
  

  QMRO: qmroHref
• Hartmann M, Fenton N, Dobson R (2022). Development of Bayesian Network for Multiple Sclerosis Risk Factor Interaction Analysis. nameOfConference

  
  

  DOI: 10.1007/978-3-031-20837-9_2

  
  

  QMRO: qmroHref
• Camera V, Messina S, Elhadd KT et al. (2022). Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disorders. nameOfConference

  
  

  DOI: 10.1136/jnnp-2021-327206

  
  

  QMRO: qmroHref
• Baker D (2021). CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosis. nameOfConference

  
  

  DOI: 10.1016/j.msard.2021.103448

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75590
• Dobson R, Craner M, Waddingham E et al. (2021). Optimise: MS study protocol: A pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis. nameOfConference

  
  

  DOI: 10.1136/bmjopen-2021-050176

  
  

  QMRO: qmroHref
• Geys L, Parciak T, Pirmani A et al. (2021). The Multiple Sclerosis Data Alliance Catalogue Enabling Web-Based Discovery of Metadata from Real-World Multiple Sclerosis Data Sources. nameOfConference

  
  

  DOI: 10.7224/1537-2073.2021-006

  
  

  QMRO: qmroHref
• Dobson R, Baker D, Kang A et al. (2021). COVID-19 vaccine response in people with multiple sclerosis. nameOfConference

  
  

  DOI: 10.1002/ana.26251

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74690
• Foote I, Jacobs B, Watson C et al. (2021). W26. A MULTIVARIATE GENOME-WIDE ASSOCIATION STUDY OF MODIFIABLE RISK FOR ALZHEIMER'S DISEASE: 269 LOCI ASSOCIATED WITH BRAIN HEALTH. nameOfConference

  
  

  DOI: 10.1016/j.euroneuro.2021.08.115

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75837
• Yam C, Rog D, Ford H et al. (2021). UK variance in DMT advice and prescribing in MS and pregnancy: impact of the UK consensus on pregnancy in multiple sclerosis ABN guidelines. nameOfConference

  
  

  DOI: 10.1016/j.msard.2021.103272

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74545
• Kuri A, Jacobs BM, Leddy S et al. (2021). Evaluation of remote assessments for multiple sclerosis in an in-home setting. nameOfConference

  
  

  DOI: 10.1016/j.msard.2021.103125

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/73142
• Jacobs BM, Noyce AJ, Bestwick J et al. (2021). Gene-Environment Interactions in Multiple Sclerosis: A UK Biobank Study. nameOfConference

  
  

  DOI: 10.1212/NXI.0000000000001007

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/70963
• Jacobs BM, Smets I, Giovannoni G et al. (2021). Regarding: Nicotinic acetylcholine receptors α7 and α9 modify tobacco smoke risk for multiple sclerosis. nameOfConference

  
  

  DOI: 10.1177/1352458520969941

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69385
• Dobson R (2021). Differing Impact of DMT on Relapse and Progression: Time to Consider Inflammation and Neuroprotection Separately?. nameOfConference

  
  

  DOI: 10.1212/WNL.0000000000012356

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/72400
• Leavitt VM, Dobson R, Svennigsson A (2021). Perinatal Depression and Anxiety in Multiple Sclerosis: Treatable Distress. nameOfConference

  
  

  DOI: 10.1212/WNL.0000000000012101

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/71702
• Garjani A, Hunter R, Law G et al. (2021). Mental health of people with multiple sclerosis during the COVID-19 outbreak: A prospective cohort and cross-sectional case-control study of the UK MS Register. nameOfConference

  
  

  DOI: 10.1177/13524585211020435

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/71706
• Dobson R, Hellwig K (2021). Use of disease-modifying drugs during pregnancy and breastfeeding. nameOfConference

  
  

  DOI: 10.1097/WCO.0000000000000922

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/71028
• Dobson R, ALLEN-PHILBEY K, Giovannoni G et al. (2021). Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis. nameOfConference

  
  

  DOI: 10.1016/j.msard.2021.103028

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/71833
• Taylor TRP, Galloway J, Davies R et al. (2021). Demyelinating Events Following Initiation of Anti-TNFα Therapy in the British Society for Rheumatology Biologics Registry in Rheumatoid Arthritis. nameOfConference

  
  

  DOI: 10.1212/NXI.0000000000000992

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/71493
• Garjani A, Middleton RM, Hunter R et al. (2021). COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies. nameOfConference

  
  

  DOI: 10.1016/j.msard.2021.102939

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/71868
• Jensen MP, Jacobs BM, Dobson R et al. (2021). Lower Lymphocyte Count is Associated With Increased Risk of Parkinson's Disease. nameOfConference

  
  

  DOI: 10.1002/ana.26034

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/70059
• Krysko KM, Bove R, Dobson R et al. (2021). Treatment of Women with Multiple Sclerosis Planning Pregnancy. nameOfConference

  
  

  DOI: 10.1007/s11940-021-00666-4

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74543
• Jitlal M, Amirthalingam G, Karania T et al. (publicationYear). The influence of socioeconomic deprivation on dementia mortality, age at death and quality of diagnosis: a nationwide death records study in England and Wales 2001-2017. nameOfConference

  
  

  DOI: 10.3233/JAD-210089

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/70919
• Dobson R, Fenton N, Hartmann M (2021). Current Review and Next Steps for Artificial intelligence in Multiple Sclerosis risk research. nameOfConference

  
  

  DOI: 10.1016/j.compbiomed.2021.104337

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/71187
• Hone L, Jacobs B, Noyce A et al. (2021). Age-specific effects of childhood BMI on multiple sclerosis risk: a Mendelian Randomisation study. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75629
• Hone L, Jacobs B, Marshall C et al. (2021). Age-specific effects of childhood Body Mass Index on multiple sclerosis risk. nameOfConference

  
  

  DOI: 10.1101/2021.09.12.21263445

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/78265
• Stennett A, Allen-Philbey K, Begum T et al. (2021). An evaluation of remote monitoring in people with MS during the COVID-19 pandemic. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75538
• Bove R, Pasquarelli N, Borriello F et al. (2021). B-cell levels and immunity in breastfed infants of women with MS treated with ocrelizumab: design of a phase 4 study (SOPRANINO). nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75631
• Thomson A, Dobson R, Baker D et al. (2021). Digesting science: Developing educational activities about multiple sclerosis, prevention and treatment to increase the confidence of affected families. nameOfConference

  
  

  DOI: 10.1016/j.msard.2020.102624

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/70066
• Huxford B, Haque T, Joseph A et al. (2021). HbA1c correlates with motor and cognitive outcome scores in patients with Parkinson's disease and type 2 diabetes. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74691
• Dobson R, Bove R, Borriello F et al. (2021). Pregnancy and infant outcomes in women receiving ocrelizumab for the treatment of multiple sclerosis. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75637
• Ostrem B, Anderson A, Conway S et al. (2021). Pregnancy outcomes and peripartum disease activity in moderately and severely disabled women with MS. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Hellwig K, Pasquarelli N, Borriello F et al. (2021). Rationale and design of a phase 4 study exploring B-cell levels and immune responses in infants born to women with MS who were exposed to ocrelizumab up to 6 months before or during the first trimester of pregnancy (the MINORE study). nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75640
• Evangelou N, Garjani A, Dasnair R et al. (2021). Self-diagnosed COVID-19 in people with multiple sclerosis: A community-based cohort of the UK MS Register. nameOfConference

  
  

  DOI: 10.1136/jnnp-2020-324449

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/67162
• Vickaryous N, Asardag AN, Chance R et al. (2021). Seroconversion following vaccination against SARS-CoV-2 in people with MS: impact of disease modifying therapy. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75630
• Foote I, Jacobs B, Mathlin G et al. (2021). The Genetic Architecture of Alzheimer’s Disease Risk: A Genomic Structural Equation Modelling Study. nameOfConference

  
  

  DOI: 10.1101/2021.02.23.21252211

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/72648
• Simpson-Yap S, Pirmani A, De Brouwer E et al. (2021). Updated results of the COVID-19 in MS global data sharing initiative validate consistent associations of anti-CD20 and other reported risk factors with severe COVID-19 outcomes. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75636
• Hartmann M, Fenton N, Dobson R (2021). Using Bayesian networks to understand multiple sclerosis risk factor interactions. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75627
• Bothongo PL, Jitlal M, Parry E et al. (2020). Ethnic and socioeconomic determinants of dementia risk: A nested case‐control study in the population of East London. nameOfConference

  
  

  DOI: 10.1002/alz.037869

  
  

  QMRO: qmroHref
• Vickaryous N, Jitlal M, Jacobs BM et al. (2020). Remote testing of vitamin D levels across the UK MS population—A case control study. nameOfConference

  
  

  DOI: 10.1371/journal.pone.0241459

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69546
• Auger SD, Jacobs BM, Dobson R et al. (2020). Big data, machine learning and artificial intelligence: a neurologist's guide.. nameOfConference

  
  

  DOI: 10.1136/practneurol-2020-002688

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/67605
• Auger S, Jacobs B, Dobson R et al. (2020). Navigating a world of big data, machine learning and artificial intelligence: a neurologist's guide. nameOfConference

  
  

  DOI: 10.1136/practneurol-2020-002688

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/67242
• Jacobs B, Belete D, Bestwick J et al. (2020). Parkinson’s disease determinants, prediction and gene-environment interactions in the UK Biobank. nameOfConference

  
  

  DOI: 10.1136/jnnp-2020-323646

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66809
• Leddy S, Dobson R (2020). Multiple sclerosis. nameOfConference

  
  

  DOI: 10.1016/j.mpmed.2020.06.008

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/67140
• Dobson R, Giovannoni G, Cuzick J (publicationYear). Estimated and projected burden of multiple sclerosis attributable to smoking and childhood and adolescent high body-mass index: a comparative risk assessment. nameOfConference

  
  

  DOI: 10.1093/ije/dyaa151

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66806
• Dobson R (publicationYear). MS, pregnancy and COVID-19. nameOfConference

  
  

  DOI: 10.1177/1352458520949152

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66821
• Jacobs B, Taylor T, Awad A et al. (2020). Summary-data-based mendelian randomisation prioritises potential druggable targets for Multiple Sclerosis. nameOfConference

  
  

  DOI: 10.1093/braincomms/fcaa119

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65644
• Taylor TR, Jacobs BM, Giovannoni G et al. (2020). Prevalence and demographics of multiple sclerosis-associated uveitis: a UK biobank study. nameOfConference

  
  

  DOI: 10.1016/j.msard.2020.102209

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66030
• Peeters LM, Parciak T, Walton C et al. (2020). COVID-19 in people with multiple sclerosis: A global data sharing initiative.. nameOfConference

  
  

  DOI: 10.1177/1352458520941485

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66201
• Reyes S, Ramsay M, Ladhani S et al. (2020). Protecting people with multiple sclerosis through vaccination. nameOfConference

  
  

  DOI: 10.1136/practneurol-2020-002527

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68522
• Krysko KM, Graves JS, Dobson R et al. (2020). Sex effects across the lifespan in women with multiple sclerosis. nameOfConference

  
  

  DOI: 10.1177/1756286420936166

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/67928
• Kuri A, Jacobs BM, Vickaryous N et al. (2020). Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom. nameOfConference

  
  

  DOI: 10.1186/s12889-020-09049-x

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65285
• Dobson R, Jokubaitis V, Giovannoni G (2020). Change in pregnancy-associated multiple sclerosis relapse rates over time: a meta-analysis. nameOfConference

  
  

  DOI: 10.1016/j.msard.2020.102241

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/64764
• Dobson R, Mowry EM (2020). Breastfeeding may reduce postpartum relapse in some women with multiple sclerosis.. nameOfConference

  
  

  DOI: 10.1212/WNL.0000000000009369

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65298
• Dobson R, Jitlal M, Marshall CR et al. (2020). Ethnic and Socioeconomic Associations with Multiple Sclerosis Risk. nameOfConference

  
  

  DOI: 10.1002/ana.25688

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/62858
• Dobson R, Jacobs B, Giovannoni G et al. (publicationYear). Systematic review and meta-analysis of the association between Epstein-Barr virus, Multiple Sclerosis, and other risk factors. nameOfConference

  
  

  DOI: 10.1177/1352458520907901

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/63739
• Jokubaitis VG, Dobson R (2020). Reader response: Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis.. nameOfConference

  
  

  DOI: 10.1212/WNL.0000000000009063

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68388
• Jokubaitis V, Dobson R (publicationYear). Family planning is the second most relevant factor for treatment decisions after disease activity. nameOfConference

  
  

  DOI: 10.1177/1352458520907902

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/63008
• Dobson R, Noyce A, Giovannoni G et al. (2020). BMI and low serum vitamin D are causal risk factors for Multiple Sclerosis: a Mendelian Randomisation study. nameOfConference

  
  

  DOI: 10.1212/NXI.0000000000000662

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/62737
• Garjani A, Hunter R, Nicholas R et al. (2020). Anxiety affects the general well-being of people with ms during the COVID-19 pandemic more than the infection itself. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69804
• Leddy S, Jacobs B, Giovannoni G et al. (2020). Bone health, fracture risk, and Multiple Sclerosis: a UK Biobank study. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68234
• Garjani A, Evangelou N, Das Nair R et al. (2020). COVID-19 in people with MS: a large community-based study of the UK MS register. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69805
• Taylor T, Luis J, Dobson R et al. (2020). Demographics of multiple sclerosis associated uveitis at moorfields eye hospital. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69807
• Taylor T, Galloway J, Adam R et al. (2020). Demyelinating events following initiation of anti-tnfα therapy in the british society for rheumatology biologics registry in rheumatoid arthritis. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69808
• Jacobs B, Giovannoni G, Dobson R (2020). Environmental exposures associated with Multiple Sclerosis: a UK Biobank study. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68240
• Jacobs B, Noyce A, Bestwick J et al. (2020). Gene-environment interactions in multiple sclerosis: a uk biobank study. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69809
• Belete D, Jacobs B, Bestwick J et al. (2020). Parkinson's disease determinants, prediction and gene-environment interactions in the UK Biobank. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Leddy S, Jacobs BM, Giovannoni G et al. (2020). To examine the impact of Multiple Sclerosis on bone health and explore mechanisms for this association.. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Vickaryous N, Garjani A, Jacobs B et al. (2020). Vitamin D levels in the UK MS population and COVID-19 susceptibility. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69841
• Jacobs BM, Giovannoni G, Cuzick J et al. (2019). Systematic review and meta-analysis of the association between Epstein-Barr virus, Multiple Sclerosis, and other risk factors. nameOfConference

  
  

  DOI: 10.1177/1352458520907901

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/67272
• DOBSON R (2019). Visibility and representation of women in multiple sclerosis research. nameOfConference

  
  

  DOI: 10.1212/WNL.0000000000007276

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/56468
• Dobson R, Dassan P, Roberts M et al. (2019). UK consensus on pregnancy in multiple sclerosis: 'Association of British Neurologists' guidelines.. nameOfConference

  
  

  DOI: 10.1136/practneurol-2018-002060

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/54858
• Dobson R, Jitlal M, Marshall C et al. (2019). Obesity is not associated with MS in a socially and ethnically diverse population. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66396
• Vickaryous N, Jitlal M, Middleton R et al. (2019). Vitamin D levels in the UK MS population. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66719
• Waubant E, Amezcua L, Sicotte N et al. (2018). Gender Inequities in the Multiple Sclerosis Community: A Call for Action. nameOfConference

  
  

  DOI: 10.1002/ana.25359

  
  

  QMRO: qmroHref
• Dobson R (2018). Clinical commentary on 'Life-threatening vitamin D intoxication due to intake of ultra-high doses in multiple sclerosis: a note of caution'.. nameOfConference

  
  

  DOI: 10.1177/1352458518807053

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/51423
• Dobson R, Giovannoni G (2018). Multiple Sclerosis - a review.. nameOfConference

  
  

  DOI: 10.1111/ene.13819

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/48023
• Thomson A, Aldam R, Giovannoni G et al. (2018). Making science digestible: the development of educational activities for children with a parent with MS, and the need to better engage families. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65723
• Dobson R, Cock HR, Brex P et al. (2018). Vitamin D supplementation. nameOfConference

  
  

  DOI: 10.1136/practneurol-2017-001720

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/51003
• Dobson R, Kuhle J, Middeldorp J et al. (2017). Epstein-Barr-negative MS: a true phenomenon?. nameOfConference

  
  

  DOI: 10.1212/NXI.0000000000000318

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/34427
• Middleton RM, Rodgers WJ, Giovannoni G et al. (2017). A Comparison of participant supplied EDSS scores and clinically submitted data via the UK MS Register. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/64994
• Dobson R, Ramagopalan S, Topping J et al. (2016). A Risk Score for Predicting Multiple Sclerosis.. nameOfConference

  
  

  DOI: 10.1371/journal.pone.0164992

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/18832
• Collins CDE, Ivry B, Bowen JD et al. (2016). A comparative analysis of Patient-Reported Expanded Disability Status Scale tools. nameOfConference

  
  

  DOI: 10.1177/1352458515616205

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/54862
• Binks S, Dobson R (2016). Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.. nameOfConference

  
  

  DOI: 10.1007/s11914-016-0320-5

  
  

  QMRO: qmroHref
• Dobson R, Alvares D (2016). The difficulties with vitamin B12. nameOfConference

  
  

  DOI: 10.1136/practneurol-2015-001344

  
  

  QMRO: qmroHref
• Topping J, Dobson R, Lapin S et al. (2016). The effects of intrathecal rituximab on biomarkers in multiple sclerosis. nameOfConference

  
  

  DOI: 10.1016/j.msard.2016.01.001

  
  

  QMRO: qmroHref
• Davis AG, Dobson R, Kaninia S et al. (2016). Atraumatic needles for lumbar puncture: Why haven’t neurologists changed?. nameOfConference

  
  

  DOI: 10.1136/practneurol-2014-001055

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/10032
• Disanto G, Adiutori R, Dobson R et al. (2016). Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome. nameOfConference

  
  

  DOI: 10.1136/jnnp-2014-309690

  
  

  QMRO: qmroHref
• Disanto G, Adiutori R, Dobson R et al. (2016). Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome. nameOfConference

  
  

  DOI: 10.1136/jnnp-2014-309690

  
  

  QMRO: qmroHref
• Binks S, Dobson R (2015). Established, new and future disease modifying therapies for MS. nameOfConference

  
  

  DOI: 10.1002/pnp.399

  
  

  QMRO: qmroHref
• Kuhle J, Gaiottino J, Leppert D et al. (2015). Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome. nameOfConference

  
  

  DOI: 10.1136/jnnp-2013-307454

  
  

  QMRO: qmroHref
• Kuhle J, Gaiottino J, Leppert D et al. (2015). Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome.. nameOfConference

  
  

  DOI: 10.1136/jnnp-2013-307454

  
  

  QMRO: qmroHref
• Kuhle J, Disanto G, Dobson R et al. (2015). Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study. nameOfConference

  
  

  DOI: 10.1177/1352458514568827

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/7011
• Leddy S, Fowler AJ, Giovanonni G et al. (2014). DEPRESSION IN MS: A SYSTEMATIC REVIEW AND META-ANALYSIS. nameOfConference

  
  

  DOI: 10.1136/jnnp-2014-309236.134

  
  

  QMRO: qmroHref
• Cooper R, Doshi A, Harris P et al. (2014). IMMUNOCOMPETENT PML—AN IMMUNOLOGICAL SCOTOMA?. nameOfConference

  
  

  DOI: 10.1136/jnnp-2014-309236.112

  
  

  QMRO: qmroHref
• Disanto G, Dobson R, Pakpoor J et al. (2014). The refinement of genetic predictors of multiple sclerosis. nameOfConference

  
  

  DOI: 10.1371/journal.pone.0096578

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/54861
• Davis A, Dobson R, Kaninia S et al. (2014). Change practice now! Using atraumatic needles to prevent post lumbar puncture headache. nameOfConference

  
  

  DOI: 10.1111/ene.12307

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12000
• Dobson R, Rudick RA, Turner B et al. (2014). Assessing treatment response to interferon-β :Is there a role for MRI?. nameOfConference

  
  

  DOI: 10.1212/WNL.0000000000000036

  
  

  QMRO: qmroHref
• Shribman S, Torsney KM, Noyce AJ et al. (2014). A service development study of the assessment and management of fracture risk in Parkinson's disease. nameOfConference

  
  

  DOI: 10.1007/s00415-014-7333-8

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/42544
• Torsney KM, Noyce AJ, Doherty KM et al. (2014). A systematic review and meta-analysis of fracture risk in Parkinson's disease. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Dobson R, Rudick RA, Turner B et al. (2014). Assessing treatment response to interferon-β Is there a role for MRI?. nameOfConference

  
  

  DOI: 10.1212/WNL.0000000000000036

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/43428
• Torsney KM, Noyce AJ, Doherty KM et al. (2014). Bone health in Parkinson's disease: A systematic review and meta-analysis. nameOfConference

  
  

  DOI: 10.1136/jnnp-2013-307307

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/37224
• Disanto G, Dobson R, Pakpoor J et al. (2014). Genetic predictors of multiple sclerosis. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Raffel J, Dobson R, Gafson A et al. (2014). Multiple sclerosis therapy and Epstein-Barr virus antibody titres. nameOfConference

  
  

  DOI: 10.1016/j.msard.2013.12.004

  
  

  QMRO: qmroHref
• Hadavi S, Baker MD, Dobson R (2014). Sustained-release fampridine in Multiple Sclerosis. nameOfConference

  
  

  DOI: 10.1016/j.msard.2013.06.003

  
  

  QMRO: qmroHref
• Leddy S, Hadavi S, Carren AM et al. (2013). A novel internet-based method of capturing outcomes in multiple sclerosis.. nameOfConference

  
  

  DOI: 10.1136/jnnp-2013-306573.9

  
  

  QMRO: qmroHref
• Hadavi S, Giovannoni G, Dobson R (2013). A service development audit of fampridine use in ms.. nameOfConference

  
  

  DOI: 10.1136/jnnp-2013-306573.178

  
  

  QMRO: qmroHref
• Dobson R, Topping J, Davis A et al. (2013). Cerebrospinal fluid and urinary biomarkers in multiple sclerosis. nameOfConference

  
  

  DOI: 10.1111/ane.12119

  
  

  QMRO: qmroHref
• Hadavi S, Shribman S, Nagy A et al. (2013). The bradykinesia-akinesia incoordination test: a simple objective test in multiple sclerosis.. nameOfConference

  
  

  DOI: 10.1136/jnnp-2013-306573.184

  
  

  QMRO: qmroHref
• Dobson R, McMillan A, Kung K et al. (2013). Think outside the box, collapse the box, and take a sharp knife to it!. nameOfConference

  
  

  DOI: 10.1136/jnnp-2013-306573.173

  
  

  QMRO: qmroHref
• Dobson R, Topping J, Ramagopalan S et al. (2013). Towards an endophenotype in multiple sclerosis.. nameOfConference

  
  

  DOI: 10.1136/jnnp-2013-306573.31

  
  

  QMRO: qmroHref
• Dobson R, Giovannoni G (2013). Bone health in multiple sclerosis: should we be doing more?. nameOfConference

  
  

  DOI: 10.2217/nmt.13.46

  
  

  QMRO: qmroHref
• James E, Dobson R, Kuhle J et al. (2013). The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis.. nameOfConference

  
  

  DOI: 10.1177/1352458513489756

  
  

  QMRO: qmroHref
• Leddy S, Hadavi S, McCarren A et al. (2013). Validating a novel web-based method to capture disease progression outcomes in multiple sclerosis.. nameOfConference

  
  

  DOI: 10.1007/s00415-013-7004-1

  
  

  QMRO: qmroHref
• Gaiottino J, Norgren N, Dobson R et al. (2013). Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases. nameOfConference

  
  

  DOI: 10.1371/journal.pone.0075091

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/54859
• Dobson R, Ramagopalan S, Davis A et al. (2013). Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude.. nameOfConference

  
  

  DOI: 10.1136/jnnp-2012-304695

  
  

  QMRO: qmroHref
• Dobson R, Giovannoni G (2013). Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis.. nameOfConference

  
  

  DOI: 10.1007/s00415-012-6790-1

  
  

  QMRO: qmroHref
• Dobson R, Yarnall A, Noyce AJ et al. (2013). Bone health in chronic neurological diseases: a focus on Multiple sclerosis and Parkinsonian syndromes.. nameOfConference

  
  

  DOI: 10.1136/practneurol-2012-000435

  
  

  QMRO: qmroHref
• Pakpoor J, Handel AE, Giovannoni G et al. (2013). Correction: Meta-analysis of the relationship between multiple sclerosis and migraine (PLoS ONE). nameOfConference

  
  

  DOI: 10.1371/annotation/274e5ef1-79aa-48f7-af62-0594d5c1354e

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/5223
• Dobson R, Giovannoni G, Ramagopalan S (2013). The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude.. nameOfConference

  
  

  DOI: 10.1136/jnnp-2012-303934

  
  

  QMRO: qmroHref
• Dobson R, Leddy SG, Gangadharan S et al. (2013). Assessing fracture risk in people with MS: a service development study comparing three fracture risk scoring systems.. nameOfConference

  
  

  DOI: 10.1136/bmjopen-2012-002508

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/54863
• Dobson R, Ramagopalan SV, Giovannoni G (2013). Genome-wide association studies: will we ever predict susceptibility to multiple sclerosis through genetics?. nameOfConference

  
  

  DOI: 10.1586/ern.13.13

  
  

  QMRO: qmroHref
• Pakpoor J, Disanto G, Gerber JE et al. (2013). The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis.. nameOfConference

  
  

  DOI: 10.1177/1352458512449682

  
  

  QMRO: qmroHref
• Leddy S, Hadavi S, McCarren A et al. (2013). A novel internet-based method of capturing outcomes in multiple sclerosis. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Dobson R, Ramagopalan S, Davis A et al. (2013). Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: A meta-analysis of prevalence, prognosis and effect of latitude. nameOfConference

  
  

  DOI: 10.1136/jnnp-2012-304695

  
  

  QMRO: qmroHref
• Dobson R, Topping J, Giovannoni G (2013). Comparison of two commercial ELISA systems for evaluating anti-EBNA1 IgG titers.. nameOfConference

  
  

  DOI: 10.1002/jmv.23446

  
  

  QMRO: qmroHref
• Evdoshenko E, Maslyanskiy A, Lapin S et al. (2013). Dynamics of B-Cell Populations in CSF and Blood in Patients Treated with a Combination of Rituximab and Mitoxantrone.. nameOfConference

  
  

  DOI: 10.1155/2013/748127

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68755
• Kuhle J, Dobson R, Bestwick JP et al. (2013). Multivariate clinically isolated syndrome (CIS) risk factor study: towards individual prognosis and treatment indication in CIS. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Dobson R, Giovannoni G, Ramagopalan S (2013). The month of birth effect in multiple sclerosis: Systematic review, meta-analysis and effect of latitude. nameOfConference

  
  

  DOI: 10.1136/jnnp-2012-303934

  
  

  QMRO: qmroHref
• Dobson R, Ramagopalan S, Giovannoni G (2012). Bone health and multiple sclerosis.. nameOfConference

  
  

  DOI: 10.1177/1352458512453362

  
  

  QMRO: qmroHref
• Dobson R, Ramagopalan S, Giovannoni G (2012). Risk of fractures in patients with multiple sclerosis: A populationbased cohort study. nameOfConference

  
  

  DOI: 10.1212/01.wnl.0000422676.74031.07

  
  

  QMRO: qmroHref
• Pakpoor J, Handel AE, Giovannoni G et al. (2012). Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine. nameOfConference

  
  

  DOI: 10.1371/journal.pone.0045295

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/54864
• Dobson R, Ramagopalan S, Giovannoni G (2012). The effect of gender in clinically isolated syndrome (CIS): a meta-analysis.. nameOfConference

  
  

  DOI: 10.1177/1352458511426740

  
  

  QMRO: qmroHref
• Dobson R (2012). Urine: An under-studied source of biomarkers in multiple sclerosis?. nameOfConference

  
  

  DOI: 10.1016/j.msard.2012.01.002

  
  

  QMRO: qmroHref
• Dobson R, Rudick RA, Giovannoni G (2012). CAN WE RELIABLY USE MRI TO MONITOR TREATMENT RESPONSE IN PATIENTS ON INTERFERON β: A SYSTEMATIC REVIEW AND META-ANALYSIS. nameOfConference

  
  

  DOI: 10.1136/jnnp-2012-304200a.127

  
  

  QMRO: qmroHref
• Davis A, Dobson R, Espasandin M et al. (2012). Cerebrospinal fluid biomarkers as outcome measures in clinical trials of MS: The significance of post lumbar puncture headaches. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Dobson R, Meier UC, Schmierer K et al. (2012). DO SIBLINGS OF PEOPLE WITH MULTIPLE SCLEROSIS (MS) HAVE MARKERS OF MS RISK?. nameOfConference

  
  

  DOI: 10.1136/jnnp-2011-301993.173

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/7015
• Disanto G, Sandve GK, Berlanga-Taylor AJ et al. (2012). Genomic Regions Associated with Multiple Sclerosis Are Active in B Cells. nameOfConference

  
  

  DOI: 10.1371/journal.pone.0032281

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/4924
• Dobson R, Ramagopalan S, Giovannoni G (2012). Osteoporosis and fracture risk in multiple sclerosis. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Raffel J, Dobson R, Giovannoni G (2012). THE EFFECT OF NATALIZUMAB AND INTERFERON-β ON URINARY FREE LIGHT CHAINS AND ANTI-EBV NUCLEAR ANTIGEN-1 ANTIBODIES IN RELAPSING REMITTING MULTIPLE SCLEROSIS. nameOfConference

  
  

  DOI: 10.1136/jnnp-2011-301993.190

  
  

  QMRO: qmroHref
• Topping J, Evdoshenko E, Dobson R et al. (2012). The effects of intrathecal rituximab on biomarkers in MS. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Dobson R, Topping J, Davis A et al. (2012). Urinary and CSF biomarkers in multiple sclerosis. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Dobson R, Giovannoni G (2012). WHY CAN'T I WIN ANY MORE?. nameOfConference

  
  

  DOI: 10.1136/jnnp-2011-301993.200

  
  

  QMRO: qmroHref
• Dobson R, Lawden M (2011). Melanoma associated retinopathy and how to understand the electroretinogram.. nameOfConference

  
  

  DOI: 10.1136/practneurol-2011-000061

  
  

  QMRO: qmroHref
• Maghzi A-H, Marta M, Bosca I et al. (2011). Viral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection?. nameOfConference

  
  

  DOI: 10.1016/j.pathophys.2010.04.003

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68754
• Handel AE, Williamson AJ, Disanto G et al. (2011). Smoking and Multiple Sclerosis: An Updated Meta-Analysis. nameOfConference

  
  

  DOI: 10.1371/journal.pone.0016149

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/5463
• Dobson R, Meier UC, Schmierer K et al. (2011). Do siblings have markers of multiple sclerosis risk?. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Meier UC, Giovannoni G (2011). More to come: humoral immune responses in MS. nameOfConference

  
  

  DOI: 10.1016/j.jneuroim.2011.09.009

  
  

  QMRO: qmroHref
• Dobson R, Meier UC, Marta M et al. (2011). Vitamin D deficiency - do we follow our own advice?. nameOfConference

  
  

  DOI: 10.7861/clinmedicine.11-6-521

  
  

  QMRO: qmroHref
• Dobson R, Feldmann M, Thompson AJ et al. (2010). INCREASED URINARY FREE IMMUNOGLOBULIN LIGHT CHAIN EXCRETION IN PATIENTS WITH MULTIPLE SCLEROSIS. nameOfConference

  
  

  DOI: 10.1136/jnnp.2010.226340.159

  
  

  QMRO: qmroHref
• Dobson R, Lawden M (2010). CP1 Darkness visible. nameOfConference

  
  

  DOI: 10.1136/jnnp.2010.226340.66

  
  

  QMRO: qmroHref
• Ramagopalan SV, Dobson R, Meier UC et al. (2010). Multiple sclerosis: risk factors, prodromes, and potential causal pathways.. nameOfConference

  
  

  DOI: 10.1016/S1474-4422(10)70094-6

  
  

  QMRO: qmroHref
• Dobson R, Miller RF, Palmer HE et al. (2010). Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis.. nameOfConference

  
  

  DOI: 10.1016/j.jneuroim.2010.01.012

  
  

  QMRO: qmroHref

Supervision

• Benjamin Jacobs – Genetic determinants of multiple sclerosis risk in diverse ancestral backgrounds (MRC)
• Brook Huxford – Remote biomarkers in Parkinson’s disease (Wolfson)
• Morghan Hartman – Using Bayesian methodology to understand complex disease (PanBayesian)
• Heather Mah – Using social capital to understand PPI in MS (Horne Family Foundation)
• Imogen Collier – Menopause and multiple sclerosis (to start Sept 2022)